- Home
- KALV vs GDEV Comparison
KALV vs GDEV Comparison
Compare KALV & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- GDEV
- Stock Information
- Founded
- KALV N/A
- GDEV 2009
- Country
- KALV United States
- GDEV Cyprus
- Employees
- KALV N/A
- GDEV N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- GDEV EDP Services
- Sector
- KALV Health Care
- GDEV Technology
- Exchange
- KALV Nasdaq
- GDEV Nasdaq
- Market Cap
- KALV 523.1M
- GDEV 520.6M
- IPO Year
- KALV N/A
- GDEV N/A
- Fundamental
- Price
- KALV $11.18
- GDEV $29.00
- Analyst Decision
- KALV Strong Buy
- GDEV Buy
- Analyst Count
- KALV 4
- GDEV 2
- Target Price
- KALV $29.00
- GDEV $70.00
- AVG Volume (30 Days)
- KALV 247.5K
- GDEV 6.1K
- Earning Date
- KALV 12-05-2024
- GDEV 11-19-2024
- Dividend Yield
- KALV N/A
- GDEV N/A
- EPS Growth
- KALV N/A
- GDEV N/A
- EPS
- KALV N/A
- GDEV 2.48
- Revenue
- KALV N/A
- GDEV $443,165,000.00
- Revenue This Year
- KALV N/A
- GDEV N/A
- Revenue Next Year
- KALV $539.64
- GDEV $6.12
- P/E Ratio
- KALV N/A
- GDEV $11.85
- Revenue Growth
- KALV N/A
- GDEV N/A
- 52 Week Low
- KALV $7.21
- GDEV $19.00
- 52 Week High
- KALV $16.88
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- KALV 46.78
- GDEV 43.82
- Support Level
- KALV $10.78
- GDEV $27.50
- Resistance Level
- KALV $12.12
- GDEV $32.60
- Average True Range (ATR)
- KALV 0.72
- GDEV 3.36
- MACD
- KALV -0.07
- GDEV -1.11
- Stochastic Oscillator
- KALV 41.20
- GDEV 9.83
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.